Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

NXLIW

Nexalin Technologies (NXLIW)

Nexalin Technologies Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:NXLIW
DatumZeitQuelleÜberschriftSymbolFirma
30/01/202523h15Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:NXLIWNexalin Technologies Inc
29/01/202523h26Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:NXLIWNexalin Technologies Inc
29/01/202523h25Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:NXLIWNexalin Technologies Inc
24/01/202522h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NXLIWNexalin Technologies Inc
23/01/202517h00GlobeNewswire Inc.Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session, Today, January 23NASDAQ:NXLIWNexalin Technologies Inc
14/01/202514h30GlobeNewswire Inc.Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025NASDAQ:NXLIWNexalin Technologies Inc
10/01/202522h35Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:NXLIWNexalin Technologies Inc
23/12/202416h00GlobeNewswire Inc.Nexalin Technology Completes Phase 1of its Innovative Virtual ClinicNASDAQ:NXLIWNexalin Technologies Inc
20/12/202418h35Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:NXLIWNexalin Technologies Inc
26/11/202416h00GlobeNewswire Inc.New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation MarketNASDAQ:NXLIWNexalin Technologies Inc
11/11/202414h00GlobeNewswire Inc.Nexalin Technology CEO Provides Letter to ShareholdersNASDAQ:NXLIWNexalin Technologies Inc
08/11/202422h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NXLIWNexalin Technologies Inc
01/11/202419h31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NXLIWNexalin Technologies Inc
01/11/202419h00GlobeNewswire Inc.Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5thNASDAQ:NXLIWNexalin Technologies Inc
01/11/202415h34GlobeNewswire Inc.Nexalin Technology Regains Compliance with Nasdaq Continued Listing RequirementsNASDAQ:NXLIWNexalin Technologies Inc
30/10/202415h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NXLIWNexalin Technologies Inc
28/10/202413h30GlobeNewswire Inc.Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's DiseaseNASDAQ:NXLIWNexalin Technologies Inc
22/10/202420h15GlobeNewswire Inc.Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VANASDAQ:NXLIWNexalin Technologies Inc
17/10/202414h30GlobeNewswire Inc.New Study Shows Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer’s PatientsNASDAQ:NXLIWNexalin Technologies Inc
14/10/202414h30GlobeNewswire Inc.Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory AffairsNASDAQ:NXLIWNexalin Technologies Inc
02/10/202420h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NXLIWNexalin Technologies Inc
19/09/202422h31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NXLIWNexalin Technologies Inc
05/09/202415h00GlobeNewswire Inc.Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid TreatmentNASDAQ:NXLIWNexalin Technologies Inc
18/07/202414h30GlobeNewswire Inc.Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use RecoveryNASDAQ:NXLIWNexalin Technologies Inc
01/07/202420h45GlobeNewswire Inc.Nexalin Technology Announces Closing of $5.2 Million Public OfferingNASDAQ:NXLIWNexalin Technologies Inc
28/06/202403h15GlobeNewswire Inc.Nexalin Technology Announces Pricing of $5.2 Million Public OfferingNASDAQ:NXLIWNexalin Technologies Inc
26/06/202415h00GlobeNewswire Inc.Nexalin Technology Announces Positive Clinical Study Data in Major Depressive Disorder and Publication of Clinical Trial Results in Leading Scientific JournalNASDAQ:NXLIWNexalin Technologies Inc
20/06/202414h30GlobeNewswire Inc.Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer’s and DementiaNASDAQ:NXLIWNexalin Technologies Inc
18/06/202423h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NXLIWNexalin Technologies Inc
14/06/202415h53Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:NXLIWNexalin Technologies Inc
 Showing the most relevant articles for your search:NASDAQ:NXLIW